Daniel Skovronsky - Net Worth and Insider Trading
Daniel Skovronsky Net Worth
The estimated net worth of Daniel Skovronsky is at least $67 Million dollars as of 2024-10-02. Daniel Skovronsky is the SVP, CSO, and Pres. LRL of Eli Lilly and Co and owns about 75,818 shares of Eli Lilly and Co (LLY) stock worth over $67 Million. Details can be seen in Daniel Skovronsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Skovronsky has not made any transactions after 2019-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Skovronsky
Daniel Skovronsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Skovronsky owns 2 companies in total, including Myriad Genetics Inc (MYGN) , and Eli Lilly and Co (LLY) .
Click here to see the complete history of Daniel Skovronsky’s form 4 insider trades.
Insider Ownership Summary of Daniel Skovronsky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYGN | Myriad Genetics Inc | 2020-07-21 | director |
| LLY | Eli Lilly and Co | 2019-10-25 | SVP & CSO & and Pres. LRL |
Daniel Skovronsky Latest Holdings Summary
Daniel Skovronsky currently owns a total of 1 stock. Daniel Skovronsky owns 75,818 shares of Eli Lilly and Co (LLY) as of October 25, 2019, with a value of $67 Million.
Latest Holdings of Daniel Skovronsky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2019-10-25 | 75,818 | 884.48 | 67,059,505 |
Holding Weightings of Daniel Skovronsky
Daniel Skovronsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Skovronsky has made a total of 1 transactions in Eli Lilly and Co (LLY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eli Lilly and Co is the acquisition of 5,000 shares on October 25, 2019, which cost Daniel Skovronsky around $543,050.
Insider Trading History of Daniel Skovronsky
- 1
Daniel Skovronsky Trading Performance
GuruFocus tracks the stock performance after each of Daniel Skovronsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Skovronsky is 24.35%. GuruFocus also compares Daniel Skovronsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Skovronsky within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Skovronsky's insider trading performs compared to the benchmark.
Performance of Daniel Skovronsky
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.25 | | | | | |
| Relative Return to S&P 500(%) | 3.07 | | | | | |
Daniel Skovronsky Ownership Network
Daniel Skovronsky Owned Company Details
What does Myriad Genetics Inc do?
Who are the key executives at Myriad Genetics Inc?
Daniel Skovronsky is the director of Myriad Genetics Inc. Other key executives at Myriad Genetics Inc include Chief Scientific Officer Dale Muzzey , director & President and CEO Paul J Diaz , and SVP & Chief of Staff Margaret Ancona .
Myriad Genetics Inc (MYGN) Insider Trades Summary
Over the past 18 months, Daniel Skovronsky made no insider transaction in Myriad Genetics Inc (MYGN). Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 242,844 shares made by Paul J Diaz , a net sale of 60,000 shares made by Richard Bryan Riggsbee , and a net sale of 16,214 shares made by Daniel K Spiegelman .
In summary, during the past 3 months, insiders sold 92,150 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 92,150 shares. During the past 18 months, 402,408 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 402,408 shares.
Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myriad Genetics Inc Insider Transactions
Daniel Skovronsky Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Skovronsky. You might contact Daniel Skovronsky via mailing address: Lilly Corporate Center, Indianapolis In 46285.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
